GE HealthCare Technologies (GE HealthCare Technologies) Debt-to-EBITDA : 2.79 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

GE HealthCare Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,116 Mil. GE HealthCare Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8,747 Mil. GE HealthCare Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was $3,536 Mil. GE HealthCare Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.79.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for GE HealthCare Technologies's Debt-to-EBITDA or its related term are showing as below:

GEHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.12 Med: 1.41 Max: 2.81
Current: 2.81

During the past 5 years, the highest Debt-to-EBITDA Ratio of GE HealthCare Technologies was 2.81. The lowest was 0.12. And the median was 1.41.

GEHC's Debt-to-EBITDA is ranked worse than
52.74% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs GEHC: 2.81

GE HealthCare Technologies Debt-to-EBITDA Historical Data

The historical data trend for GE HealthCare Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Debt-to-EBITDA Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

0.14

0.12

2.67

2.81

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial							2.31	3.05	2.97	2.77	2.79

Competitive Comparison of GE HealthCare Technologies's Debt-to-EBITDA

For the Health Information Services subindustry, GE HealthCare Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GE HealthCare Technologies's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Debt-to-EBITDA falls into.

GE HealthCare Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

GE HealthCare Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1116	+	8747)	/	3513
	=	2.81

GE HealthCare Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1116	+	8747)	/	3536
	=	2.79

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

GE HealthCare Technologies (NAS:GEHC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

GE HealthCare Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

GEHC:Mexico L0T:Germany

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.

Executives

Kevin Michael O'neill	officer: CEO, PDx	500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott	officer: CEO, Ultrasound	500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro	officer: Chief Financial Officer	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela	officer: CEO, Imaging	500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout	officer: Chief Technology Officer	500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski	officer: Ch. Supply Chain & Serv. Ofc.	500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr	director	GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg	director	100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick	officer: CEO, Patient Care Solutions	500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman	director	21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic	director	ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell	director	8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden	director	C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez	officer: GC & Corporate Secretary	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061